Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
Signs of a potential allergic response include: Widespread rash or hives appearing beyond the injection site Intense itching affecting multiple body areas Swelling of the face, lips, tongue, or throat (angioedema) Skin reactions accompanied by difficulty breathing or swallowing These symptoms may indicate hypersensitivity and warrant prompt medical evaluation
10.1002/jor.21107 19 CesarecV.BecejacT.MisicM.DjakovicZ.OlujicD.DrmicD.et al (2013)
The delayed gastric emptying caused by tirzepatide can increase GLP-1 effects on levothyroxine absorption if they are taken in close proximity
Women of childbearing age should discuss effective contraception before starting treatment, and should inform their doctor promptly if they become pregnant
Ghrelin is a new endogenous peptide, discovered in 1999 by Kojima et al., as the result of a search for an endogenous ligand for an orphan receptor of known structure and function
&srotate=0)
US$ 26.75
US$ 22.12
US$ 26.58
US$ 21.67
US$ 21.84
US$ 28.05
US$ 25.73
